regeneron - Search News

News

Regeneron To Buy 23andMe For $256M

Houston Chronicle on MSN · 3h

Pharmaceutical company Regeneron buying 23andMe for $256 million

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase Monday.

ABC News on MSN · 21h

Regeneron Pharmaceuticals to buy 23andMe for $256M

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March following a series of setbacks.

CBS News on MSN · 1d

Regeneron to buy 23andMe out of bankruptcy for $256 million

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's privacy policies.

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Pharmaceutical Technology1h

ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care

All participants will initially undergo a run-in period on standardised medium-dose ICS/LABA to confirm persistent lack of ...

5h

Viz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease (COPD)

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year ...

Regeneron Acquires Bankrupt 23andMe's Assets for $256 Million Amidst Potential Layoffs in San Francisco

Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results